Title |
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant
|
---|---|
Published in |
Science Translational Medicine, September 2018
|
DOI | 10.1126/scitranslmed.aap9489 |
Pubmed ID | |
Authors |
Ying Taur, Katharine Coyte, Jonas Schluter, Elizabeth Robilotti, Cesar Figueroa, Mergim Gjonbalaj, Eric R Littmann, Lilan Ling, Liza Miller, Yangtsho Gyaltshen, Emily Fontana, Sejal Morjaria, Boglarka Gyurkocza, Miguel-Angel Perales, Hugo Castro-Malaspina, Roni Tamari, Doris Ponce, Guenther Koehne, Juliet Barker, Ann Jakubowski, Esperanza Papadopoulos, Parastoo Dahi, Craig Sauter, Brian Shaffer, James W Young, Jonathan Peled, Richard C Meagher, Robert R Jenq, Marcel R M van den Brink, Sergio A Giralt, Eric G Pamer, Joao B Xavier |
Abstract |
Antibiotic treatment can deplete the commensal bacteria of a patient's gut microbiota and, paradoxically, increase their risk of subsequent infections. In allogeneic hematopoietic stem cell transplantation (allo-HSCT), antibiotic administration is essential for optimal clinical outcomes but significantly disrupts intestinal microbiota diversity, leading to loss of many beneficial microbes. Although gut microbiota diversity loss during allo-HSCT is associated with increased mortality, approaches to reestablish depleted commensal bacteria have yet to be developed. We have initiated a randomized, controlled clinical trial of autologous fecal microbiota transplantation (auto-FMT) versus no intervention and have analyzed the intestinal microbiota profiles of 25 allo-HSCT patients (14 who received auto-FMT treatment and 11 control patients who did not). Changes in gut microbiota diversity and composition revealed that the auto-FMT intervention boosted microbial diversity and reestablished the intestinal microbiota composition that the patient had before antibiotic treatment and allo-HSCT. These results demonstrate the potential for fecal sample banking and posttreatment remediation of a patient's gut microbiota after microbiota-depleting antibiotic treatment during allo-HSCT. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 31 | 22% |
United Kingdom | 13 | 9% |
Spain | 6 | 4% |
Japan | 5 | 4% |
Australia | 5 | 4% |
Switzerland | 4 | 3% |
Mexico | 3 | 2% |
France | 3 | 2% |
Singapore | 3 | 2% |
Other | 17 | 12% |
Unknown | 51 | 36% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 71 | 50% |
Scientists | 61 | 43% |
Practitioners (doctors, other healthcare professionals) | 9 | 6% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 358 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 65 | 18% |
Student > Ph. D. Student | 52 | 15% |
Student > Master | 32 | 9% |
Student > Bachelor | 32 | 9% |
Student > Postgraduate | 21 | 6% |
Other | 59 | 16% |
Unknown | 97 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 75 | 21% |
Biochemistry, Genetics and Molecular Biology | 51 | 14% |
Immunology and Microbiology | 41 | 11% |
Agricultural and Biological Sciences | 33 | 9% |
Engineering | 10 | 3% |
Other | 43 | 12% |
Unknown | 105 | 29% |